TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

被引：0
|
作者：
Ahluwalia, M. S. [1 ,2 ]
Khosla, A. A. [1 ,2 ]
Ozair, A. [1 ]
Kotecha, R. R. [1 ,2 ]
McDermott, M. W. [1 ,2 ]
Mehta, M. P. [1 ,2 ]
Sandoval-Leon, A. C. [1 ]
Mahtani, R. [1 ,2 ]
Peereboom, D. M. [3 ]
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
JS06.5.A
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Frequency of asymptomatic brain metastases in Her-2 positive breast cancer patients.
    Niwinska, A
    Tacikowska, M
    Pienkowski, T
    Lemanska, I
    Bauer-Kosinska, B
    Glogowska, I
    Rudnicka, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S181 - S182
  • [32] PyrotInib in combination with Capecitabine for trasTUzumab-REsistant, HER2-positive advanced breast cancer (PICTURE): a multicenter phase 2 trial
    Hu, Xichun
    Cao, Jun
    Teng, Yue'e
    Li, Hui-Ping
    Zhang, Lili
    Ouyang, Quchang
    Xie, Weimin
    Pan, Yueyin
    Song, Zhenchuan
    Ling, Xiaoling
    Wu, Xiaohong
    Xu, Jingwei
    Li, Li
    Ren, Liping
    Wang, Hong
    Zhou, Dongxian
    Luo, Jing
    CANCER RESEARCH, 2023, 83 (05)
  • [33] Tucatinib vs placebo added to trastuzumab and capecitabine in previously treated HER2+metastatic breast cancer with and without brain metastases (HER2CLIMB)
    Curigliano, G.
    Murthy, R.
    Loi, S.
    Okines, A.
    Paplomata, E.
    Hamilton, E.
    Hurvitz, S. A.
    Cameron, D.
    Borges, V.
    Bedard, P.
    Oliveira, M.
    Jakobsen, E. H.
    Bachelot, T.
    Shachar, S. S.
    Mueller, V.
    Carey, L. A.
    Loibl, S.
    Feng, W.
    Walker, L. N.
    Winer, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S62 - S63
  • [34] Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
    Lin, Nancy U.
    Dieras, Veronique
    Paul, Devchand
    Lossignol, Dominique
    Christodoulou, Christos
    Stemmler, Hans-Joachim
    Roche, Henri
    Liu, Minetta C.
    Greil, Richard
    Ciruelos, Eva
    Loibl, Sibylle
    Gori, Stefania
    Wardley, Andrew
    Yardley, Denise
    Brufsky, Adam
    Blum, Joanne L.
    Rubin, Stephen D.
    Dharan, Bernie
    Steplewski, Klaudia
    Zembryki, Denise
    Oliva, Cristina
    Roychowdhury, Debasish
    Paoletti, Paolo
    Winer, Eric P.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1452 - 1459
  • [35] The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
    Petrelli, Fausto
    Ghidini, Michele
    Lonati, Veronica
    Tomasello, Gianluca
    Borgonovo, Karen
    Ghilardi, Mara
    Cabiddu, Mary
    Barni, Sandro
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 141 - 148
  • [36] Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
    Rupert Bartsch
    Anna Sophie Berghoff
    Julia Furtner
    Maximilian Marhold
    Elisabeth Sophie Bergen
    Sophie Roider-Schur
    Angelika Martina Starzer
    Heidrun Forstner
    Beate Rottenmanner
    Karin Dieckmann
    Zsuzsanna Bago-Horvath
    Helmuth Haslacher
    Georg Widhalm
    Aysegül Ilhan-Mutlu
    Christoph Minichsdorfer
    Thorsten Fuereder
    Thomas Szekeres
    Leopold Oehler
    Birgit Gruenberger
    Christian F. Singer
    Ansgar Weltermann
    Rainer Puhr
    Matthias Preusser
    Nature Medicine, 2022, 28 : 1840 - 1847
  • [37] Phase 2 trial of tucatinib plus trastuzumab deruxtecan in patients with HER2+locally advanced or metastatic breast cancer with and without brain metastases (HER2CLIMB-04, trial in progress).
    Krop, Ian E.
    Carey, Lisa A.
    Ramos, Jorge
    Chen, Yiyi
    Hamilton, Erika P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Furtner, Julia
    Marhold, Maximilian
    Bergen, Elisabeth Sophie
    Roider-Schur, Sophie
    Starzer, Angelika Martina
    Forstner, Heidrun
    Rottenmanner, Beate
    Dieckmann, Karin
    Bago-Horvath, Zsuzsanna
    Haslacher, Helmuth
    Widhalm, Georg
    Ilhan-Mutlu, Aysegul
    Minichsdorfer, Christoph
    Fuereder, Thorsten
    Szekeres, Thomas
    Oehler, Leopold
    Gruenberger, Birgit
    Singer, Christian F.
    Weltermann, Ansgar
    Puhr, Rainer
    Preusser, Matthias
    NATURE MEDICINE, 2022, 28 (09) : 1840 - +
  • [39] Stereotactic Radiosurgery for Breast Cancer Brain Metastases: Improved Outcomes in Her2 Amplified Patients
    Gupta, G. P.
    McLane, A.
    Stewart, L.
    Zhang, Z.
    Seidman, A.
    Beal, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S5 - S5
  • [40] HER2CLIMB-04: Phase II trial of tucatinib plus trastuzumab deruxtecan in patients with HER2+locally advanced or metastatic breast cancer with and without brain metastases
    Carey, L. A.
    Krop, I.
    Ramos, J.
    Feng, W.
    Hamilton, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S510 - S511
12345